Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscularly as a single 0.8mL dose.

A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

WHO and the Uganda Health Ministry have launched a first-ever vaccine trial for the species of Ebola at the center of an ...

After figuring out how to grow recombinant bacteria on an industrial scale and how to harvest the insulin they produce, it was time to bring the recombinant insulin to the market. In 1982 Food and ...

Using this cis-activation strategy in primary cells and muscle, we have demonstrated an increase in transgene expression of more than 600-fold from a minimal simian virus 40 (SV40) promoter and an ...

Recombinant MPXV A35R protein, which is similar to Vaccinia virus A33R protein, has been created by Sino Biological. A33R protein from the Vaccinia virus is a homolog of MPXV A35R protein.

In a global first, Uganda’s Ministry of Health, the World Health Organization, and other partners launched a first-ever ...

The Recombinant DNA Technology Market size is expected to be worth around USD 1288.5 Bn by 2032 from USD 786.7 Bn in 2023, growing at a CAGR of 5.8% As scientific and technological advancements ...

Janet Mertz’s work with simian virus 40 DNA during her graduate years was pivotal for developing DNA recombination as we now know it. Berg was awarded one-half of the Nobel Prize in Chemistry in 1980 ...